Company Analysis - Allergan, Inc.
RNCOS E-Services Private Limited, May 2011, Pages: 30
Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions.
The study covers information on the business structure, areas of operation, products and services offered by the company. It comprises SWOT analysis, Key Ratios, and financials that aid investors in gaining an insight into the company's performance.
The report is based on extensive research using data available from credible publications, trade journals, industry associations and the company sources.
Report Highlights
- Provides a comprehensive version of the company's performance
- Offers key financial data, ratio and SWOT analysis
- Tracks major M&A trends and developments
- Business Profile, SWOT analysis and financial information on top five competitors
- View on the company by our analysts
- Supplemented with graphs and tabular information wherever necessary
1. Company Overview
1.1 History
1.2 Business Overview
1.3 Organizational Structure
1.4 Major Mergers & Acquisitions
1.5 Ticker Codes at Various Stock Exchange Listings
1.6 Management Profile
2. Product & Services
2.1 Product & Services - An Overview
2.2 Revenue & Income Summary by Geographical Distribution
2.3 Revenue & Income Summary by Product Division
3. Financial Information for the Fiscal Year
3.1 Financial Summary for the Fiscal Year
3.2 Breakup of Revenue & Sales Trends
3.3 Ratio & Market Indicators
3.4 Earning & Income Estimates
3.5 Stock Analysis
4. SWOT Analysis
4.1 Strength
4.2 Weakness
4.3 Opportunity
4.4 Threats
5. Top Competitors (Key Financials & SWOT Analysis)
5.1 Alcon, Inc.
5.2 Johnson & Johnson
5.3 Pfizer, Inc.
6. Analyst View
List of Tables
Table 1-1: Allergan, Inc. - Major Mergers & Acquisitions (2001-2008)
Table 1-2: Allergan, Inc. - Ticker Codes at various Stock Exchanges
Table 1-3: Allergan, Inc. - Key Management People
Table 3-1: Allergan, Inc. - Financial Summary (Million US$), 2010
Table 3-2: Allergan, Inc. - Breakup of Revenue & Sales (Million US$), 2008-2010
Table 3-3: Allergan, Inc. - Key Financial Ratios (2008-2010)
Table 3-4: Allergan, Inc. - Earning & Income Estimates (Million US$), 2008-2010
Table 5-1: Alcon, Inc. - Key Financials (Million US$), 2008-2010
Table 5-2: Alcon, Inc. - SWOT Analysis
Table 5-3: Johnson & Johnson - Key Financials (Million US$), FY 2009 to FY 2011
Table 5-4: Johnson & Johnson - SWOT Analysis
Table 5-5: Pfizer, Inc. - Key Financials (Million US$), 2008-2010
Table 5-6: Pfizer, Inc. - SWOT Analysis
List of Charts
Figure 2-1: Allergan, Inc. - Net Sales by Geographical Distribution (Million US$), 2009 & 2010
Figure 2-2: Allergan, Inc. - Net Sales by Product Division (Million US$), 2009 & 2010
Figure 3-1: Allergan, Inc. - Stock Chart
- Alcon, Inc.
- Johnson & Johnson
- Pfizer, Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network